Ameritas Investment Partners’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Buy |
34,669
+8,639
| +33% | +$43.7K | 0.01% | 1381 |
|
|
2025
Q1 | $138K | Hold |
26,030
| – | – | ﹤0.01% | 1494 |
|
|
2024
Q4 | $176K | Buy |
26,030
+1,875
| +8% | +$12.7K | 0.01% | 1403 |
|
|
2024
Q3 | $159K | Buy |
24,155
+3,903
| +19% | +$25.7K | 0.01% | 1481 |
|
|
2024
Q2 | $152K | Buy |
20,252
+6,692
| +49% | +$50.2K | 0.01% | 1452 |
|
|
2024
Q1 | $135K | Hold |
13,560
| – | – | ﹤0.01% | 1544 |
|
|
2023
Q4 | $134K | Hold |
13,560
| – | – | ﹤0.01% | 1541 |
|
|
2023
Q3 | $104K | Buy |
13,560
+2,290
| +20% | +$17.5K | ﹤0.01% | 1630 |
|
|
2023
Q2 | $84.2K | Buy |
11,270
+1,129
| +11% | +$8.43K | ﹤0.01% | 1712 |
|
|
2023
Q1 | $67.6K | Hold |
10,141
| – | – | ﹤0.01% | 1790 |
|
|
2022
Q4 | $88.3K | Hold |
10,141
| – | – | ﹤0.01% | 1685 |
|
|
2022
Q3 | $107K | Hold |
10,141
| – | – | ﹤0.01% | 1439 |
|
|
2022
Q2 | $82K | Buy |
10,141
+1,233
| +14% | +$9.97K | ﹤0.01% | 1657 |
|
|
2022
Q1 | $64K | Hold |
8,908
| – | – | ﹤0.01% | 1918 |
|
|
2021
Q4 | $153K | Buy |
8,908
+6,751
| +313% | +$116K | 0.01% | 1411 |
|
|
2021
Q3 | $50K | Buy |
2,157
+500
| +30% | +$11.6K | ﹤0.01% | 2156 |
|
|
2021
Q2 | $60K | Buy |
+1,657
| New | +$60K | ﹤0.01% | 2068 |
|